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Regulation of prices and reimbursement of medicinal products 
Abstract 
Medicinal products are essentially part of every human life. It is therefore desirable to 
ensure that they are offered on the market at a fair and affordable price, precisely through price 
and reimbursement regulation. The aim of this diploma thesis is to analyse how the regulation 
of prices and reimbursements applies to human medicinal products in the provision of 
outpatient health care, the price and reimbursement of which is decided by the State Institute 
for Drug Control in administrative proceedings. In order to achieve this goal, the thesis is 
divided into four parts. 
The first part defines the basic concepts needed understand the meaning and purpose of 
the system of price and reimbursement regulation, such as a medicinal product, price or 
reimbursement. Furthermore, this part is devoted to the types of administrative acts occurring 
in the field of price and reimbursement regulation and introduces the Ministry of Health and 
the State Institute for Drug Control as the most important administrative authorities operating 
in this field. The second part analyses the legislation effective until 31st December 2007. The 
forms of administrative activity then performed by the Ministry of Health and the Ministry of 
Finance are analysed in more detail, using the knowledge of administrative acts from the first 
part. The second part also analyses the impact of European Union law in this field, in particular 
the Transparency Directive, the key judgement of the Constitutional Court, which repealed the 
effective regulation of reimbursement regulation at that time, and the Act on the Stabilization 
of Public Budgets, which introduced a completely new system of pricing and reimbursement. 
The third and fourth part of this thesis is focused on the current legal regulation of the process 
of pricing and reimbursement of medicinal products in administrative proceedings, as well as 
their changes or cancellation. These parts also deal with issues of participation in these 
administrative proceedings, the locus standi of the parties to judicial review, or the issue of 
providing free healthcare. 
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